Related references
Note: Only part of the references are listed.Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
Iduna Fichtner et al.
CLINICAL CANCER RESEARCH (2008)
Oncolytic viruses in cancer therapy
Markus J. V. Vaha-Koskela et al.
CANCER LETTERS (2007)
A new model of patient tumor-derived breast cancer Xenografts for preclinical assays
Elisabetta Marangoni et al.
CLINICAL CANCER RESEARCH (2007)
Adjuvant treatment of colorectal cancer
Brian M. Wolpin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts.: Evidence linking EGFR signaling to gefitinib antitumor response
Jean-Gabriel Judde et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The tumour microenvironment as a target for chemoprevention
Adriana Albini et al.
NATURE REVIEWS CANCER (2007)
Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter
J. J. Davis et al.
CANCER GENE THERAPY (2006)
Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus
Fengqin Dong et al.
CLINICAL CANCER RESEARCH (2006)
Gene therapy for malignant glioma: Current clinical status
KJ Pulkkanen et al.
MOLECULAR THERAPY (2005)
Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme:: biological and clinical results
F Colombo et al.
CANCER GENE THERAPY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development
JK Peterson et al.
EUROPEAN JOURNAL OF CANCER (2004)
Clonogenic assay with established human tumour xenografts:: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery
HH Fiebig et al.
EUROPEAN JOURNAL OF CANCER (2004)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Anticancer drug response and expression of molecular marker in early-passage xenotransplanted colon carcinomas
I Fichtner et al.
EUROPEAN JOURNAL OF CANCER (2004)
Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter
D Jacob et al.
CLINICAL CANCER RESEARCH (2004)
Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants
B Hann et al.
JOURNAL OF VIROLOGY (2003)
Replicative retroviral vectors for cancer gene therapy
SK Solly et al.
CANCER GENE THERAPY (2003)
Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax
H LeBlanc et al.
NATURE MEDICINE (2002)
Induced apoptosis supports spread of adenovirus vectors in tumors
J Mi et al.
HUMAN GENE THERAPY (2001)
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
JI Johnson et al.
BRITISH JOURNAL OF CANCER (2001)
Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas
N Shinoura et al.
CANCER GENE THERAPY (2000)
Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
AM Chinnaiyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)